John Prensner honored with prestigious Damon Runyon Cancer Research Foundation award

John Prensner, M.D., Ph.D., has received a Clinical Investigator Award from the Damon Runyon Cancer Research Foundation for his proposal:

“Therapeutic opportunities and mechanistic insights of protein-RNA dyssynchrony in medulloblastoma.”

The award supports outstanding early-career physician-scientists whose disease-oriented research has the potential to directly impact patients.

Prensner was recognized as a leading pediatric cancer researcher whose work is focused on understanding the biological underpinnings of high-risk medulloblastoma and developing new treatment options. 

The award was given to 6 recipients in total, and designed to increase the number of physicians capable of translating their discoveries in the lab into viable therapeutics for cancer patients.

Congratulations John!

John Prensner, M.D., Ph.D.
Assistant Professor of Pediatrics
Assistant Professor of Biological Chemistry
Read Michigan Medicine’s announcement written BY JENNIFER BOUDRIE.

The Damon Runyon Cancer Research Foundation was founded in 1946 by famed radio broadcaster Walter Winchell in honor of his good friend, sportswriter and journalist Damon Runyon. His death from cancer spurred Winchell to announce to listeners to send anything they could afford to help find a cure for this horrible disease. The result was a flood of donations and support from celebrities such as Bob Hope, Marlene Dietrich and Milton Berle. Winchell led fundraising efforts until his own death from cancer in 1972.

Read more on the Damon Runyon Cancer Research Foundation website.

Similar Posts

  • |

    U-M study sheds light on how bacteria control their detoxification

    By Morgan Sherburne, Michigan News Bacteria need to constantly adapt to compete against other species for nutrient sources and to survive against threats such as antibiotics and toxins. In an effort to understand how bacteria control and regulate this adaptation, University of Michigan researchers from the Center for RNA Biomedicine are examining how RNA polymerase—the…

  • U-M Researchers Collaborate on $3 Million Grant to Treat Rare Forms of Cystic Fibrosis

    Center RNA Therapeutics Director Michelle Hastings, and faculty members Rachel Niederer and Alexandra Piotrowski-Daspit address the need for new treatment strategies, and the subsequent barriers that must be overcome for success, by working together as an interdisciplinary team with unique expertise in CFTR physiology, designing RNA therapeutics, identifying targetable regulatory sequences, and developing engineered delivery…

  • Welcome Stephanie Moon, Ph.D.

    Dr. Stephanie Moon is Assistant Professor in the Department of Human Genetics at the University of Michigan (U-M) Medical School, and a faculty scholar at the U-M Center for RNA Biomedicine. She joined our RNA community in January 2020, and is the first RNA BSI faculty hire. Dr. Moon brings to Michigan an extensive experience…

  • |

    To splice or not to splice…

    by Elisabeth Paymal In an article published in the journal RNA [1] , Karan Bedi, a bioinformatician in Mats Ljungman’s lab, Department of Radiation Oncology at the University of Michigan Medical School, investigated the efficiency of splicing across different human cell types. The results were surprising in that the splicing process appears to be quite…

  • Kevin Weeks, Ph.D. – Keynote speaker, 2021 RNA Symposium

    KEYNOTE SPEAKER 2: March 25, 2021, 12:10–1:05 pm More information on the Symposium Blog by MiSciWriters “Structure-based discovery of new functions in large RNAs” Kevin Weeks, Ph.D. Kenan Distinguished Professor of Chemistry Chemistry, University of North Carolina The Kevin Weeks Lab TALK ABSTRACT The functions of many RNA molecules – including mRNAs, long non-coding RNAs,…

  • RNA Innovation Seminar Series

    The Center for RNA Biomedicine offers bi-weekly RNA Innovation Seminars that feature visiting professors, U of M faculty, and students. The seminars cover a broad array of topics about RNA research and its application. In addition to learning about the latest research in the field, it is an opportunity to meet colleagues, network, and foster…